Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial - Ezekowitz, MD; Pollack, CV; Sanders, P (Am Heart J, 2016)
et al.